Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Investigating brain activity patterns in movement disorders

Official title: Oscillatory Activity in Basal Ganglia Circuits During Normal and Pathological Movement

Run by University Hospital, Bordeaux · NCT06241924 · Data updated 2026-11-12

This study is testing how brain activity changes during movement in people with Parkinson's disease and epilepsy to see if it helps us understand their conditions better.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment30 (estimated)
SponsorUniversity Hospital, Bordeaux
Academic / other
Locations1 site (Bordeaux)
StatusRecruiting
StartedFebruary 5, 2024
Main results expectedFebruary 5, 2027
Study endsFebruary 5, 2027
Registry record updatedJuly 23, 2025
Trial IDNCT06241924 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 to 75 with Parkinson's disease who have undergone electrode implantation or individuals with drug-resistant epilepsy undergoing pre-surgical assessment.

Probably not a fit

Patients who are unable to provide informed consent or have serious psychiatric or somatic illnesses may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research aims to explore the oscillatory activity in the cortico-subcortical network during normal and pathological movements in patients with Parkinson's disease and drug-resistant epilepsy. By utilizing high-resolution electroencephalogram (EEG) and stereo-electro-encephalography (SEEG), the study will collect local field potentials while participants perform a simple motor task. The goal is to understand the relationship between the characteristics of these oscillations and movement patterns, which could provide insights into the underlying mechanisms of these disorders.

Why it matters

Potential benefit: If successful, this study could enhance our understanding of movement disorders and lead to improved treatment strategies for patients with Parkinson's disease and epilepsy.

How similar studies have gone: Other studies have shown promise in understanding brain oscillations in movement disorders, but this specific approach using high-resolution techniques is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria :

* Male or Female
* Between 18 and 75 years of age
* With Parkinson's disease and already operated with implantation of electrodes in the Subthalamic nucleus connected to a PERCEPT (TM) device.
* Giving free, informed, written consent signed by the participant and the investigator Or
* With drug-resistant epilepsy and benefiting from a phase II pre-surgical assessment with intracerebral electrophysiological exploration by stereo-EEG
* With at least one electrode exploring the basal ganglia or the thalamus.
* Able to perform the simple motor task
* Affiliated or beneficiary of a social security scheme;
* Giving free, informed, written consent signed by the participant and the investigator

Exclusion criteria:

* Be incapable of giving consent personally
* Be subject to a legal protection measure or be placed under judicial protection;
* Being pregnant or breastfeeding
* Present a serious and/or decompensated somatic or psychiatric illness

Where it's running

  • CHU de Bordeaux
    Bordeaux, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.